Preparation and characterization of parthenolide nanocrystals for enhancing therapeutic effects of sorafenib against advanced hepatocellular carcinoma.

Liang, Pan

Preparation and characterization of parthenolide nanocrystals for enhancing therapeutic effects of sorafenib against advanced hepatocellular carcinoma. [electronic resource] - International journal of pharmaceutics Jun 2020 - 119375 p. digital

Publication Type: Comparative Study; Journal Article

1873-3476

10.1016/j.ijpharm.2020.119375 doi


Animals
Antineoplastic Combined Chemotherapy Protocols--chemistry
Carcinoma, Hepatocellular--drug therapy
Cell Movement--drug effects
Cell Proliferation--drug effects
Delayed-Action Preparations
Dose-Response Relationship, Drug
Drug Compounding
Drug Liberation
Drug Stability
Drug Synergism
Female
Hep G2 Cells
Humans
Liver Neoplasms--drug therapy
Mice, Inbred BALB C
Mice, Nude
Nanoparticles
Sesquiterpenes--chemistry
Solubility
Sorafenib--chemistry
Tumor Burden--drug effects
Xenograft Model Antitumor Assays